Valuation ALLOVIRPAR

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-14 EDT			5-day change	1st Jan Change
4.080 ^USD	+5.15%		-7.40%	-58.41%

25-03-19	Kalaris Therapeutics Completes Merger with AlloVir	MT
25-03-17	AlloVir, Inc.(NasdaqCM:ALVR) dropped from NASDAQ Composite Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024
Market Cap ¹	2,370	802.5	463.8	75.22	48.07
Change	-	-66.14%	-42.2%	-83.78%	-36.1%
Enterprise Value (EV) ¹	2,023	584.4	265.4	-81.29	-70.22
Change	-	-71.11%	-54.58%	-130.63%	13.62%
P/E	-14.8x	-4.72x	-2.33x	-0.37x	-0.82x
PBR	6.72x	3.47x	2.08x	0.52x	0.43x
PEG	0.2x	-0.85x	0.1x	0x	0x
Capitalization / Revenue	-	-	-	-	-
EV / Revenue	-	-	-	-	-
EV / EBITDA	-28.4x	-3.45x	-1.56x	0.45x	1.28x
EV / EBIT	-28.4x	-3.44x	-1.55x	0.45x	1.27x
EV / FCF	-56.1x	-14.6x	-3.19x	1.23x	4.11x
FCF Yield	-1.78%	-6.85%	-31.3%	81.4%	24.4%
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-59.67	-63	-50.62	-42.09	-11.73
Distribution rate	-	-	-	-	-
Net sales ¹	-	-	-	-	-
EBITDA ¹	-71.24	-169.6	-170.5	-180.9	-54.86
EBIT ¹	-71.31	-169.8	-171.2	-181.3	-55.26
Net income ¹	-69.78	-172	-168.7	-190.4	-58.77
Net Debt ¹	-347.6	-218.1	-198.4	-156.5	-118.3
Reference price ²	884.119	297.620	117.990	15.635	9.660
Nbr of stocks (in thousands)	2,681	2,696	3,931	4,811	4,976
Announcement Date	2/12/21	2/10/22	2/15/23	3/15/24	3/7/25